DR. WHITTEMORE G. TINGLEY, M.D.
Osteopathic Medicine at Parnassus Ave, San Francisco, CA
License number
California G85848
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G85848
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
350 Parnassus Ave STE 300, San Francisco, CA 94143
Phone
(415) 353-2873
(415) 353-2528 (Fax)
(415) 353-2528 (Fax)
Personal information
See more information about WHITTEMORE G. TINGLEY at radaris.comName
Address
Phone
356 Stonecrest Dr, San Francisco, CA 94132
119 Knollview Way, San Francisco, CA 94131
Professional information
Clinical Development At Genentech
Position:
Clinical Development at Genentech, Cardiologist & Assistant Clinical Professor at University of California, San Francisco
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Genentech
since Aug 2009
-
Clinical Development
University of California, San Francisco
since 1999
-
Cardiologist & Assistant Clinical Professor
CardioDx
Jan 2007 - Jul 2009
-
Clinical R&D
Gladstone Institute of Cardiovascular Disease
2002 - 2006
-
Fellow
The Johns Hopkins University School of Medicine
Jul 1996 - Jun 1999
-
Medicine Resident
Education:
The Johns Hopkins University School of Medicine 1989 - 1996
M.D. & Ph.D., Medicine, Neuroscience Brown University 1985 - 1989
A.B., Philosophy, Neuroscience
M.D. & Ph.D., Medicine, Neuroscience Brown University 1985 - 1989
A.B., Philosophy, Neuroscience
Predictive Models And Methods For Diagnosing And Assessing Coronary Artery Disease
US Patent:
2011018, Jul 28, 2011
Filed:
Oct 10, 2008
Appl. No.:
12/682579
Inventors:
Steve Rosenberg - Oakland CA, US
Susan Daniels - Mountain View CA, US
Michael R. Elashoff - Redwood City CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Amy J. Sehnert - San Francisco CA, US
Nicholas F. Paoni - Encinitas CA, US
Susan Daniels - Mountain View CA, US
Michael R. Elashoff - Redwood City CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Amy J. Sehnert - San Francisco CA, US
Nicholas F. Paoni - Encinitas CA, US
Assignee:
CARDIODX, INC. - Palo Alto CA
International Classification:
G06G 7/60
US Classification:
703 11
Abstract:
Biomarkers useful for diagnosing and assessing the extent of coronary artery disease (CAD) are provided, along with kits for measuring their expression. The invention also provides predictive models, based on the biomarkers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples. In a preferred embodiment, the biomarkers are organized into clustered groups. The expression level of the biomarkers within a group are highly correlated to each other in normal and disease states. Expression values of genes chosen from each of two, three, four or five of the clustered gene groups, A, B, C, D, E may be used. Alternatively, expression values of genes chosen from the groups are combined into a metagene. Preferred biomarkers include S100A12, S100A8, S100A9, BCL2A1, and F5 (group A); XK, P62, and FECH (group B); TUBB2 (group C); IFNG, PDGFB, VSIG4, and TNF (group D); CSF3R, TLR5, CD46, and NCF1 (group E); S100A12, S100A9, BCL2A1, TXN and CSTA (group I); OLIG1, OLIG2, ADORA3, CLC, and SLC29A1 (group II); and CBS and ARG1 (group IV).
Determination Of Coronary Artery Disease Risk
US Patent:
2011001, Jan 20, 2011
Filed:
Jun 15, 2010
Appl. No.:
12/816232
Inventors:
Steven Rosenberg - Oakland CA, US
Michael R. Elashoff - Redwood City CA, US
Philip Beineke - Mountain View CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Susan E. Daniels - Mountain View CA, US
Michael R. Elashoff - Redwood City CA, US
Philip Beineke - Mountain View CA, US
James A. Wingrove - Sunnyvale CA, US
Whittemore G. Tingley - San Francisco CA, US
Susan E. Daniels - Mountain View CA, US
Assignee:
CARDIODX - Palo Alto CA
International Classification:
G06F 19/00, G01N 33/48, G06N 5/02
US Classification:
702 19, 706 52
Abstract:
Markers and methods useful for assessing coronary artery disease in a subject are provided, along with kits for measuring their expression. Also provided are predictive models, based on the markers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples.
Whittemore Gooch Tingley, San Francisco CA
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
UCSF Medical Center / Moffitt-Long Hospitals
521 Parnassus Ave, San Francisco, CA 94143
521 Parnassus Ave, San Francisco, CA 94143
Education:
Johns Hopkins University (1996)
Predictive Models And Method For Assessing Age
US Patent:
2012003, Feb 9, 2012
Filed:
Apr 14, 2010
Appl. No.:
13/264360
Inventors:
Steve Rosenberg - Oakland CA, US
Whittemore G. Tingley - San Francisco CA, US
Michael R. Elashoff - Redwood City CA, US
Whittemore G. Tingley - San Francisco CA, US
Michael R. Elashoff - Redwood City CA, US
Assignee:
CARDIODX, INC. - Palo Alto CA
International Classification:
G06N 5/04
US Classification:
706 52
Abstract:
Biomarkers useful for diagnosing and assessing physiological age are provided, along with kits for measuring their expression. The invention also provides predictive models, based on the biomarkers, as well as computer systems, and software embodiments of the models for scoring and optionally classifying samples. In a preferred embodiment, the biomarkers include a group of biomarkers whose expression levels are highly correlated to each other. In a preferred embodiment, expression levels of CD248; CD248 and SLC 1A7; CD248 and one, two, three or four of the group consisting of CCR7, B3GAT1, VSIG4 and LR-RN3; or CD248, SLC1A7 and one, two, three or four of the group consisting of CCR7, B3GAT1, VSIG4 and LRRN3 are determined.